@AustinKulasekar Profile picture

Austin Kulasekararaj

@AustinKulasekar

I am trying it out

Similar User
AML Hub photo

@AML_Hub

Charlie Craddock CBE photo

@charliecraddock

Pramila Krishnamurthy photo

@drpramilak

DrDonalMcLornan photo

@DrLornan

vp photo

@vicpotter123

Antonio Pagliuca photo

@ProfBMT

Dr Deepti Radia photo

@DeeptiRadia

Priya Sriskandarajah 🇺🇦💙💛 photo

@PriyaSriRajah

paresh vyas photo

@pvyas_oxford

Michelle Kenyon💙 photo

@michellekenyon5

Varun Mehra photo

@docbmt

Emma M. Groarke photo

@emmamgroarke

Adele Fielding photo

@AdeleKFielding

PNH Global Alliance photo

@GlobalPnh

ASCENT - Accelerated Stem CEll traNsplant Trials photo

@crctuASCENTteam

Austin Kulasekararaj Reposted

Yet another failed randomized trial of HMA combination in higher risk #MDSsm, this time with RARA agonist tamibarotene: n=245, CR rate 23.8% with combo vs 18.8% HMA alone, p=0.20. This is becoming a depressing and recurring theme, @Dr_AmerZeidan ir.syros.com/press-releases…


Austin Kulasekararaj Reposted

Data-driven, harmonised classification system for MDS sciencedirect.com/science/articl… It took a global effort for this project using largest MDS cohort to date from Moffitt and Genomed datasets. Thx to all my dear coauthors @MoffittNews @Dr_AmerZeidan @drsomedeb @genomed4all @ic_MDS


Austin Kulasekararaj Reposted

Many congratulations to my colleague @mikewdennis on your award of an honorary chair @OfficialUoM Long overdue and richly deserved. New door sign needed Prof Mike! 👏👏

Congratulations to the new Honorary Clinical Chairs appointed by Manchester Academic Health Science Centre for 2024. These positions are awarded to individuals who have made a major contribution to their clinical specialty, including excellence in research and education. Read…

Tweet Image 1


Austin Kulasekararaj Reposted

If anyone missed it, see below for virtual viewing of an excellent #BMFsm and #MDSsm conference!

Your opportunity for on-demand viewing of the Sessions from the 2024 AAMDSIF Bone Marrow Failure Scientific Symposium awaits! Follow this link for all the sessions: cvent.me/mQOXMZ

Tweet Image 1
Tweet Image 2
Tweet Image 3


Austin Kulasekararaj Reposted

More from @jadothm et al re NPM1m AML getting intensive therapy! -FLT3-ITD, DNMT3A, WT1, non-ABD NPM1 assoc w/ MRD+ & worse OS (all but FLT3-ITD assoc w/ relapse in MRD- dz) -difficult to identify groups benefiting from allo when NPM1 MRD- post 2 cycles sciencedirect.com/science/articl…

Tweet Image 1

Austin Kulasekararaj Reposted

🌟 Meet Maria, Chair of @PNHSupport and leader in patient advocacy. From NZ to UK, she champions PNH patients' rights. She founded PNH Global Alliance and is also an @eupatients graduate, dedicated to healthcare research & empowering patients. #MeetMaria #PatientAdvocacy🌍

Tweet Image 1

Austin Kulasekararaj Reposted

Reporting variants, a must know in 2024 #EBMT24 @TheEBMT_Trainee @TheEBMT

Tweet Image 1

Austin Kulasekararaj Reposted

Great panel discussion at the @aamds anniversary summit on the merits of immunosuppressive therapy and stem cell transplant in #SAA. #BMFsm @bhavishap29 @AustinKulasekar @AmyDeZern

Tweet Image 1
Tweet Image 2
Tweet Image 3
Tweet Image 4

Thanks for the invite. Enjoyed the discussions with colleagues and a stalwart like Dr Deeg @aamdsif

Amy DeZern Moderates the panel on "Moving the Needle: Alternative Donor BMT" with H. Joachim Deeg, Austin Kulasekararaj, and Bhavisha Patel at #AAMDSIF40th

Tweet Image 1


Amazing journey into history of marrow disease #AA #MDS #PNH by the great haem historian @DavidSteensma at @aamdsif It was a joy watching you dwell into history @MikkaelSekeres

I look like I am pleading for something… better treatments for marrow failure disorders. Thanks @aamdsif for the invitation to present the keynote address today on the history of our understanding of bone marrow, in honor of the Foundation’s 40th year (& 100 research grants.)



Austin Kulasekararaj Reposted

Professor David Rees at the launch of the Lancet Haematology Commission on Sickle Cell Disease at the Houses of Parliament. A very proud moment for our lab! Congrats to all authors @DavidRe40855993 @KCLcancer_pharm

Tweet Image 1

Austin Kulasekararaj Reposted

Thanks @LeukUK for the shoutout 📣 please do get in touch- we’d love to hear from you! @mikewdennis @pvyas_oxford @charliecraddock

📢 Are you a patient or carer with lived experience of AML? Have you been treated with Venetoclax and Azacitidine? Researchers are developing a new clinical trial and they need your input! Interested? Please send your contact details to lewis@leukaemiauk.org.uk by 31 October.

Tweet Image 1


Austin Kulasekararaj Reposted

I have a challenging case of paroxysmal nocturnal hemoglobinuria so I am reading about it (a lot). ABIM doesn't trust doctors to do this so they make us pay them money for fake MOC certification. Excellent free review on PNH! onlinelibrary.wiley.com/doi/full/10.10…

Tweet Image 1

Austin Kulasekararaj Reposted

Ana Rio-Machin and Kevin Rouault-Pierre will use the award to decipher the role of #germline variants in the RNA-helicases to improve the #EarlyDetection and management of familial myelodysplastic syndrome and acute myeloid #leukaemia [4/8]

Tweet Image 1
Tweet Image 2

Very sad indeed #MDS @ukmdsforum an eternal curse for high risk MDS #tp53 with futility of number of Ph3 trials in MDS @Dr_AmerZeidan

This is a huge blow for the #MDSsm field, but another reason why people should be more cautious about reading too much into phase 1 trials before randomized data. Gilead To Discontinue Phase 3 ENHANCE Study of Magrolimab Plus Azacitidine in Higher-Risk MDS investors.gilead.com/news/news-deta…



Austin Kulasekararaj Reposted

Succinct. At Breaking Point or Already Broken? The National Health Service in the United Kingdom | NEJM nejm.org/doi/full/10.10…


Austin Kulasekararaj Reposted

What a gifted speaker !!! ⁦@AustinKulasekar⁩ speaking about pathophysiology and clinical management of extravascular hemolysis in #PNHsm at #EHA2023

Tweet Image 1

Austin Kulasekararaj Reposted

Very proud to listen to Jens Panse of ⁦@UniklinikAachen⁩ ⁦@RWTH⁩ presenting the phase 1 data of the MASP-3 inhibitor OMS906 in patients with #PNH at #EHA2023 ! Great job, Jens ! #cioabcd

Tweet Image 1

Austin Kulasekararaj Reposted

Our dedicated clinicians explaining past to present in #PNH care & treatment from significant survival risk to life saving treatment with #unmetneed. BUT not all patients have #access still @ERNEuroBloodNet @AustinKulasekar @lichterzellen #EHA2023

Tweet Image 1

Austin Kulasekararaj Reposted

⁦⁦@AustinKulasekar⁩ on management of BTH in PNH. Great talk on the #ipigconference

Tweet Image 1
Tweet Image 2

Loading...

Something went wrong.


Something went wrong.